Evidence map›Paper›PMID 42445733›Full record

ArticleISME communications2026

Liuqing Yang, Yanfang Liu, Jingjin Li, Jiahua Lv, Qi Zhang, Minghua Cong, Hanping Shi, Heping Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ISME communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liuqing YangInner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Inner Mongolia Agricultural University, Hohhot 010018, Inner Mongolia, China.
Yanfang LiuInner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Inner Mongolia Agricultural University, Hohhot 010018, Inner Mongolia, China.
Jingjin LiInner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Inner Mongolia Agricultural University, Hohhot 010018, Inner Mongolia, China.
Jiahua LvDepartment of Radiotherapy, Sichuan Cancer Hospital, Chengdu, Sichuan 610041, China.
Qi ZhangDepartment of Colorectal Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, China.
Minghua CongDepartment of Comprehensive Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Hanping ShiDepartment of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China.
Heping ZhangInner Mongolia Key Laboratory of Dairy Biotechnology and Engineering, Inner Mongolia Agricultural University, Hohhot 010018, Inner Mongolia, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemotherapy for advanced gastric and esophageal cancer is often limited by severe gastrointestinal and systemic toxicities that profoundly impair patients' quality of life. We conducted a randomized, double-blind, placebo-controlled trial in 104 patients to evaluate whether

Indexed as

bile acidschemotherapy toxicityesophageal cancergastric cancergut–brain axismetabolomicsprobiotic intervention

Identifiers

PMID42445733
PMCPMC13362969

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.